These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30902832)

  • 1. Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.
    Madonna MC; Fox DB; Crouch BT; Lee J; Zhu C; Martinez AF; Alvarez JV; Ramanujam N
    Mol Cancer Res; 2019 Jul; 17(7):1545-1555. PubMed ID: 30902832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-simultaneous intravital microscopy of glucose uptake and mitochondrial membrane potential, key endpoints that reflect major metabolic axes in cancer.
    Zhu C; Martinez AF; Martin HL; Li M; Crouch BT; Carlson DA; Haystead TAJ; Ramanujam N
    Sci Rep; 2017 Oct; 7(1):13772. PubMed ID: 29062013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer.
    Cai H; Peng F
    J Fluoresc; 2013 Jan; 23(1):213-20. PubMed ID: 23054302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uptake of 2-NBDG by human breast cancer cells in vitro].
    Hu H; Shan XH; Zhu W; Qian H; Xu WR; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):507-10. PubMed ID: 21029693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.
    Rajaram N; Frees AE; Fontanella AN; Zhong J; Hansen K; Dewhirst MW; Ramanujam N
    PLoS One; 2013; 8(10):e76524. PubMed ID: 24204635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancer.
    Frees AE; Rajaram N; McCachren SS; Fontanella AN; Dewhirst MW; Ramanujam N
    PLoS One; 2014; 9(12):e115529. PubMed ID: 25526261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness.
    Fujita M; Imadome K; Somasundaram V; Kawanishi M; Karasawa K; Wink DA
    BMC Cancer; 2020 Sep; 20(1):929. PubMed ID: 32993545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
    Millon SR; Ostrander JH; Brown JQ; Raheja A; Seewaldt VL; Ramanujam N
    Breast Cancer Res Treat; 2011 Feb; 126(1):55-62. PubMed ID: 20390344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
    Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
    J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
    O'Neil RG; Wu L; Mullani N
    Mol Imaging Biol; 2005; 7(6):388-92. PubMed ID: 16284704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.
    Rajaram N; Reesor AF; Mulvey CS; Frees AE; Ramanujam N
    PLoS One; 2015; 10(1):e0117132. PubMed ID: 25635865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.
    Nitin N; Carlson AL; Muldoon T; El-Naggar AK; Gillenwater A; Richards-Kortum R
    Int J Cancer; 2009 Jun; 124(11):2634-42. PubMed ID: 19173294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
    Yamada K
    Biol Pharm Bull; 2018; 41(10):1508-1516. PubMed ID: 30270319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake.
    Glenister A; Simone MI; Hambley TW
    PLoS One; 2019; 14(7):e0217712. PubMed ID: 31306426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells.
    Bollig-Fischer A; Dewey TG; Ethier SP
    PLoS One; 2011 Mar; 6(3):e17959. PubMed ID: 21437235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain.
    Lemos C; Pinheiro BS; Beleza RO; Marques JM; Rodrigues RJ; Cunha RA; Rial D; Köfalvi A
    Purinergic Signal; 2015 Dec; 11(4):561-9. PubMed ID: 26446689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography.
    Sheth RA; Josephson L; Mahmood U
    J Biomed Opt; 2009; 14(6):064014. PubMed ID: 20059252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.